Yahoo
31% confirmed ORR (8 responses in 26 evaluable patients) across B7-H4 high tumors at intermediate doses 44% confirmed ORR (7 responses in 16 evaluable patients) in the subset of patients with ≤4 prior lines of therapy CAMBRIDGE, Mass., June 02, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on the development of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced additional
Yahoo
CAMBRIDGE, Mass., May 20, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on the development of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced that members of management will participate in the following upcoming investor events: TD Cowen 6th Annual Oncology Innovation SummitFormat: Fireside chatDate/Time: Tuesday, May 27, 2025, at 2:00 p.m. Eastern TimeGoldman Sachs 46t
Yahoo
Mersana Therapeutics Inc (MRSN) extends cash runway and reports promising clinical data, despite increased net loss and reduced collaboration revenue.
Yahoo
Q1 2025 Mersana Therapeutics Inc Earnings Call
Yahoo
In a release issued under the same headline earlier today by Mersana Therapeutics, Inc. (NASDAQ: MRSN), please note that there was a transcription error in the last cell of the first table. The Median OS should have been 5.7 months rather than 1.7 months. The corrected release follows: Mersana Therapeutics Provides Business Update and Announces First Quarter 2025 Financial Results Updated clinical data from Emi-Le Phase 1 dose escalation and backfill cohorts presented today at ESMO Breast Cancer
Yahoo
Mersana Therapeutics (MRSN) delivered earnings and revenue surprises of 9.52% and 62.78%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| BTAL | -33.06% | $296.22M | 1.43% |
| VIXY | -32.29% | $164.54M | 0.85% |
| TAIL | -28.55% | $99.63M | 0.59% |
| FXY | -18.47% | $816.38M | 0.4% |
| CTA | -13.54% | $1.06B | 0.76% |
| IBMN | -11.89% | $447.08M | 0.18% |
| IVOL | -11.77% | $347.03M | 1.02% |
| UNG | -11.21% | $360.54M | 1.06% |
| XHLF | -11.13% | $1.73B | 0.03% |
| FTSD | -10.92% | $231.81M | 0.25% |
| CORN | -10.54% | $44.67M | 0.2% |
| CLIP | -10.48% | $1.51B | 0.07% |
| ULST | -10.36% | $654.75M | 0.2% |
| TBLL | -10.00% | $2.13B | 0.08% |
| UDN | -9.05% | $148.33M | 0.78% |
| FXE | -8.63% | $568.94M | 0.4% |
| WEAT | -8.55% | $117.15M | 0.28% |
| SPTS | -8.43% | $5.80B | 0.03% |
| TPMN | -8.19% | $30.70M | 0.65% |
| UTWO | -8.02% | $379.52M | 0.15% |
Current Value
$0.281 Year Return
Current Value
$0.281 Year Return
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| XBI | 46.11% | $4.82B | 0.35% |
| GNOM | 46.04% | $44.57M | 0.5% |
| ARKG | 43.50% | $1.02B | 0.75% |
| IWC | 42.67% | $818.14M | 0.6% |
| IWO | 42.28% | $11.60B | 0.24% |
| IBB | 41.98% | $5.26B | 0.45% |
| KJAN | 41.73% | $287.30M | 0.79% |
| IWM | 41.28% | $63.72B | 0.19% |
| VTWO | 41.18% | $12.52B | 0.07% |
| PBE | 40.88% | $223.19M | 0.58% |
| GSSC | 40.38% | $561.54M | 0.2% |
| RDTE | 40.20% | $137.93M | 0.97% |
| SCHA | 40.10% | $17.26B | 0.04% |
| VBK | 39.70% | $19.01B | 0.07% |
| ISCG | 39.55% | $681.20M | 0.06% |
| ARKK | 39.51% | $6.85B | 0.75% |
| KJUL | 39.49% | $119.50M | 0.79% |
| QQQJ | 39.40% | $621.52M | 0.15% |
| ESML | 39.33% | $1.84B | 0.17% |
| VXF | 39.21% | $22.29B | 0.05% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| BKAG | 0.04% | $1.90B | 0% |
| DBE | -0.13% | $52.20M | 0.77% |
| MMIT | -0.15% | $1.03B | 0.3% |
| XBIL | -0.23% | $783.90M | 0.15% |
| FTSM | 0.28% | $6.37B | 0.45% |
| MMIN | 0.28% | $336.10M | 0.3% |
| JMST | -0.33% | $4.06B | 0.18% |
| BILS | 0.37% | $3.81B | 0.1356% |
| BCD | -0.38% | $279.79M | 0.3% |
| GBIL | 0.40% | $6.37B | 0.12% |
| JUCY | -0.45% | $269.70M | 0.6% |
| GVI | -0.49% | $3.42B | 0.2% |
| HTAB | -0.50% | $411.35M | 0.39% |
| SPMB | 0.55% | $6.16B | 0.04% |
| BNDX | 0.56% | $67.52B | 0.07% |
| IYK | 0.56% | $1.45B | 0.4% |
| VCRB | -0.60% | $3.13B | 0.1% |
| SHM | -0.62% | $3.41B | 0.2% |
| VTIP | 0.64% | $15.33B | 0.03% |
| TFI | -0.65% | $3.22B | 0.23% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| IGMS | 47.00% | $79.35M | -79.53% | 0.00% |
| CRNX | 45.61% | $2.76B | -33.39% | 0.00% |
| DNLI | 44.00% | $2.16B | -30.05% | 0.00% |
| DYN | 43.21% | $1.02B | -73.78% | 0.00% |
| RGNX | 41.60% | $434.35M | -20.33% | 0.00% |
| NRIX | 40.90% | $948.37M | -35.91% | 0.00% |
| CRSP | 40.60% | $4.46B | -4.14% | 0.00% |
| OVID | 40.32% | $23.50M | -56.03% | 0.00% |
| NTLA | 39.75% | $1.11B | -53.25% | 0.00% |
| RXRX | 39.18% | $2.12B | -29.12% | 0.00% |
| XNCR | 38.42% | $590.72M | -55.40% | 0.00% |
| OCUL | 38.30% | $1.51B | +41.41% | 0.00% |
| FATE | 38.26% | $128.39M | -64.56% | 0.00% |
| KRC | 38.19% | $4.13B | +7.91% | 6.20% |
| ATXS | 38.13% | $323.37M | -36.33% | 0.00% |
| AUTL | 38.06% | $625.43M | -32.66% | 0.00% |
| SYRE | 37.59% | $935.48M | -39.83% | 0.00% |
| BEAM | 37.51% | $2.00B | -15.33% | 0.00% |
| JEF | 37.51% | $11.68B | +10.91% | 2.64% |
| BN | 37.33% | $103.22B | +45.48% | 0.54% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| RYAN | -0.02% | $8.33B | +14.50% | 0.70% |
| LDOS | 0.02% | $20.93B | +10.90% | 0.96% |
| DTE | 0.06% | $27.12B | +19.63% | 3.26% |
| FE | -0.07% | $22.95B | +3.43% | 4.32% |
| SYPR | -0.08% | $48.49M | +14.05% | 0.00% |
| PEP | -0.14% | $187.12B | -16.06% | 4.02% |
| VZ | -0.20% | $183.79B | +6.01% | 6.18% |
| COR | -0.21% | $56.44B | +30.86% | 0.74% |
| HSY | -0.29% | $35.88B | -3.63% | 3.10% |
| ORLY | 0.31% | $76.35B | +31.28% | 0.00% |
| CCRN | -0.38% | $429.13M | -3.89% | 0.00% |
| NFG | -0.51% | $7.58B | +52.77% | 2.46% |
| BJ | 0.52% | $14.41B | +26.76% | 0.00% |
| HRB | 0.53% | $7.48B | -0.13% | 2.66% |
| LNTH | 0.58% | $5.51B | +0.08% | 0.00% |
| SBAC | 0.64% | $25.53B | +23.63% | 1.79% |
| NHTC | 0.67% | $52.73M | -34.10% | 17.43% |
| CLX | -0.67% | $15.36B | -5.89% | 3.90% |
| GIS | 0.67% | $29.20B | -14.66% | 4.47% |
| SBS | -0.68% | $14.57B | +48.61% | 3.04% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| CBOE | -22.46% | $24.23B | +35.36% | 1.09% |
| CME | -15.30% | $99.39B | +40.68% | 3.86% |
| NOC | -14.05% | $71.81B | +14.14% | 1.69% |
| AEP | -12.28% | $55.16B | +17.93% | 3.54% |
| MO | -11.11% | $99.67B | +28.77% | 6.90% |
| MKTX | -10.13% | $8.22B | +9.03% | 1.38% |
| MNOV | -9.47% | $62.29M | -9.29% | 0.00% |
| CL | -9.45% | $74.88B | -3.64% | 2.19% |
| CI | -9.37% | $85.59B | -1.55% | 1.81% |
| ED | -9.16% | $36.00B | +12.64% | 3.34% |
| RPRX | -9.06% | $15.25B | +39.62% | 2.38% |
| KMB | -8.07% | $43.92B | -3.75% | 3.75% |
| VHC | -8.02% | $48.19M | +108.24% | 0.00% |
| KO | -8.01% | $305.22B | +11.97% | 2.81% |
| DG | -7.21% | $25.41B | -7.95% | 2.05% |
| K | -6.95% | $27.76B | +41.17% | 2.85% |
| WBA | -6.90% | $9.95B | +3.51% | 4.36% |
| HUSA | -6.43% | $19.66M | -19.53% | 0.00% |
| AWK | -6.20% | $27.36B | +9.65% | 2.21% |
| LTM | -5.98% | $12.63B | -95.46% | 2.42% |
